JCO
 2011
DOI: 10.1200/jco.2011.29.15_suppl.e18543
|View full text |Cite
|
Sign up to set email alerts
|

Unexpected cutaneous toxicity of IGEV regimen in patients with Hodgkin lymphoma.

Ewa Paszkiewicz‐Kozik1,
Joanna Romejko‐Jarosińska2,
B. Brzeska3
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Our observation that maculopapular rash was more common among female subjects echoes an earlier report of cutaneous reactions after a different gemcitabine-containing regimen (ifosfamide, gemcitabine, and vinorelbine; IGEV). 24 The etiology of this sex difference remains unknown.…”
Section: Discussionmentioning
confidence: 99%

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial

Cole
1
,
McCarten2,
Pei
3
et al. 2018
The Lancet Oncology
73
1
65
0
View full textAdd to dashboardCite
show abstract
“…Our observation that maculopapular rash was more common among female subjects echoes an earlier report of cutaneous reactions after a different gemcitabine-containing regimen (ifosfamide, gemcitabine, and vinorelbine; IGEV). 24 The etiology of this sex difference remains unknown.…”
Section: Discussionmentioning
confidence: 99%

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial

Cole
1
,
McCarten2,
Pei
3
et al. 2018
The Lancet Oncology
73
1
65
0
View full textAdd to dashboardCite
show abstract
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.